Gamida Cell Ltd. (GMDA) Financials

GMDA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 117.7 million 117.4 million
2023-06-30 112.5 million 138.2 million
2023-03-31 105.1 million 120.5 million
2022-12-31 124.8 million 132.8 million

GMDA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -18.6 million 1.4 million
2023-06-30 -22.0 million 1.4 million
2023-03-31 -23.1 million 1.5 million
2022-12-31 -19.7 million 1.2 million

GMDA Net Income

No data available :(

GMDA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 60.4 million - 3.8 million
2023-06-30 54.1 million - 4.6 million
2023-03-31 46.8 million - 5.1 million
2022-12-31 64.7 million - 7.5 million

GMDA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 151.9 million
2023-06-30 102.2 million
2023-03-31 76.8 million
2022-12-31 63.8 million

GMDA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 12000 4.2 million 13.8 million -
2023-06-30 6000 8.7 million 6.3 million 3862
2023-03-31 827000 8.8 million 5.2 million 5576
2022-12-31 3.5 million 11.0 million 6.5 million -2.8 million

GMDA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 673000 626000
2023-06-30 - 108000
2023-03-31 - 106000
2022-12-31 - 49000

GMDA

Price: $0.03

52 week price:
0.03
2.51

Earnings Per Share: -0.82 USD

P/E Ratio: -0.47

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 182493

Market Capitalization: 5.3 million

Links: